SCHEMBL2961433

SCHEMBL2961433

OCCc1occ2ccccc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.37
HSP90AA1 P07900 1/20 0.36
HNF4A P41235 1/20 0.36
MAOB P27338 1/20 0.34
ALDH1A1 P00352 6/20 0.33
TSHR P16473 3/20 0.33
HTT P42858 1/20 0.33
HSD17B10 Q99714 4/20 0.33
KDM4E B2RXH2 4/20 0.33
HPGD P15428 3/20 0.33
GAA P10253 2/20 0.33
MAPT P10636 1/20 0.33
CYP2A6 P11509 1/20 0.32
CYP1A2 P05177 2/20 0.31
MITF O75030 1/20 0.31
LMNA P02545 1/20 0.31
TTR P02766 1/20 0.31
GLA P06280 1/20 0.31
POLB P06746 1/20 0.31
RAD52 P43351 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28869124 0.89 KDM4E (0.38) HSP90AA1HNF4AMAOBALDH1A1TSHR
SCHEMBL10596740 0.87 KDM4E (0.40) MAOBALDH1A1TSHRHSD17B10KDM4E
SCHEMBL1746782 0.83 MAOB (0.40) TDP1MAOBALDH1A1TSHRHSD17B10
SCHEMBL971316 0.80 HTR2A (0.37) ALDH1A1TSHRHSD17B10KDM4EGAA
SCHEMBL6591672 0.80 ALDH1A1 (0.32) TDP1ALDH1A1TSHRHSD17B10CYP2A6
SCHEMBL13183865 0.80 KDM4E (0.41) ALDH1A1HSD17B10KDM4EHPGDGAA
SCHEMBL7859850 0.78 KEAP1 (0.46) TDP1ALDH1A1TSHRHTTHSD17B10
SCHEMBL16684493 0.77 MAPT (0.43) TDP1GAAMAPT
SCHEMBL3983271 0.77 HTR1B (0.40) TDP1ALDH1A1TSHRHSD17B10KDM4E
SCHEMBL6002752 0.77 MAPT (0.30) TDP1ALDH1A1TSHRHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109111415-A A kind of dendrobium nobile alcaloid-derivatives, preparation method and medical usage 安徽中医药大学 2019-01-01 CN disclosed
US-7776848-B2 Spirocyclic cyclohexane compounds GRUENENTHAL GMBH (DE) 2010-08-17 US disclosed
EP-1778680-B1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES GRUENENTHAL GMBH (DE) 2008-10-08 EP disclosed
US-20070213351-A1 Spirocyclic cyclohexane compounds GRUENENTHAL GMBH (DE) 2007-09-13 US disclosed
EP-1778680-A2 SPIROCYCLIC CYCLOHEXANE DERIVATIVES Grünenthal GmbH (DE) 2007-05-02 EP disclosed
WO-2006018184-A2 SPIROCYCLIC CYCLOHEXANE DERIVATIVES Grünenthal GmbH (DE) 2006-02-23 WO disclosed
US-6300340-B1 USEFUL FOR THERAPY OF CANCER AND SOLID TUMORS ADIR ET COMPAGNIE (FR) 2001-10-09 US disclosed
US-6162822-A Bisimide compounds ADIR ET COMPAGNIE (FR) 2000-12-19 US disclosed
EP-0820985-B1 Bis imide derivatives, process for their preparation and pharmaceutical compositions containing them ADIR (FR) 2000-08-30 EP disclosed
US-5854273-A Bisimide compounds ADIR ET COMPAGNIE (FR) 1998-12-29 US disclosed
EP-0820985-A1 Bis imide derivatives, process for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1998-01-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213351-A1 Spirocyclic cyclohexane compounds PKD1, PKD2, NR3C2 TDP1 3906/4885HSP90AA1 619/4885HNF4A 1478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.